Pricing Log in Create free account

Optimi Health Corp. (OPTH) vs TherapeuticsMD, Inc. (TXMD)

Optimi Health Corp. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. TherapeuticsMD, Inc. is the larger, with a market value of $19.8M against $13.7M — 1.4× the size. Across the 8 metrics below, TherapeuticsMD, Inc. leads on 6 and Optimi Health Corp. on 2.

Valuation

Metric OPTH TXMD Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S n/m 6.12 2.08
P/B 2.86 0.74 1.79
Price to free cash flow n/m 7.36 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 84.46 2.87
Earnings yield — (1.35%) (15.94%)
Free cash flow yield (66.34%) 13.59% 0.00%

Profitability

Metric OPTH TXMD Drug Manufacturers Specialty & Generic median
Gross margin — 100.00% 53.51%
Operating margin — (120.89%) 0.00%
Net margin — (6.64%) (2.45%)
Free cash flow margin 0.00% 94.71% 0.00%
Return on equity — (0.80%) (0.80%)
Return on assets — (0.57%) (1.67%)
Return on invested capital 0.00% (13.77%) 0.00%

Growth

Metric OPTH TXMD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 27.78% 5.22%
EPS growth (last fiscal year) (1,575.96%) 73.68% 42.91%
Revenue growth, 5-year CAGR — (45.84%) 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric OPTH TXMD Drug Manufacturers Specialty & Generic median
Debt to equity 1.02 0.00 0.04
Current ratio 0.06 3.22 2.41
Net debt to EBITDA (0.67) 2.34 1.01

Dividend

Metric OPTH TXMD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric OPTH TXMD Drug Manufacturers Specialty & Generic median
Market cap 13.69m 19.80m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack